Sangamo Therapeutics Stock Slumps After Pfizer Terminates Hemophilia A Gene Therapy Partnership

In This Article:

Sangamo Therapeutics' (SGMO) shares were sinking intraday Tuesday after the company said its partner

Upgrade to read this MT Newswires article and get so much more.
A Silver or Gold subscription plan is required to access premium news articles.